BioRestorative Therapies Inc (BRTX) Key Ratios
$2.76
As on 10-Sep-2026 16:09EDT
Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 18.21 | -7.32 | -8.47 | 38.36 | 35.62 |
| EBIT | 32.84 | 59.65 | 8.59 | 13.65 | 5.66 |
| Net Profit | 32.84 | 59.65 | 8.59 | 13.70 | 8.12 |
| EPS | 33.71 | 62.51 | 16.35 | 21.24 | 14.55 |
| Book Value | -- | -- | -96.34 | -75.71 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -5,526.99 | -23,996.60 | -3,089.55 | -3,959.40 | -2,239.25 |
| Net Margin
| -- | -- | -3,089.55 | -- | -- |
| Return on equity
| -173.34 | -208.04 | -422.60 | -320.47 | -96.89 |
| Return on Capital
| -170.10 | -187.04 | -- | -314.72 | -95.22 |
| Return on Assets
| -106.00 | -143.32 | -106.50 | -174.11 | -72.15 |
| Debt to Equity (x)
| -- | -- | 0.00 | -- | 0.02 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
-314.72
|
-95.22
|
-100.37
|
-80.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-422.60
Lower than Peers by 382.27
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
-422.60
|
-320.47
|
-96.89
|
-102.66
|
-82.93
|
|
Peer Median
|
-40.33
|
--
|
--
|
--
|
--
|
ROA
-106.50
Lower than Peers by 75.25
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
-106.50
|
-174.11
|
-72.15
|
-71.73
|
-68.00
|
|
Peer Median
|
-31.24
|
--
|
--
|
--
|
--
|
EBIT Margin
-3,089.55
Lower than Peers by 3,006.96
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
-3,089.55
|
-3,959.40
|
-2,239.25
|
-10,382.33
|
-11,036.97
|
|
Peer Median
|
-82.60
|
--
|
--
|
--
|
--
|
Net Margin
-3,089.55
Lower than Peers by 2,998.25
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
-3,089.55
|
-3,959.40
|
-2,239.25
|
-7,145.20
|
-11,036.97
|
|
Peer Median
|
-91.30
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.01
Lower than Peers by 0.01
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
-0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-8.47
Lower than Peers by 62.51
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
-8.47
|
-0.10
|
1.75
|
0.22
|
1.60
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
8.59
Higher than Peers by 9.61
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
8.59
|
-58.61
|
40.68
|
-14.48
|
68.88
|
|
Peer Median
|
-1.02
|
--
|
--
|
--
|
--
|
Net Profit Growth
8.59
Higher than Peers by 16.13
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
8.59
|
-58.61
|
13.81
|
21.21
|
70.16
|
|
Peer Median
|
-7.53
|
--
|
--
|
--
|
--
|
EPS Growth
16.35
Higher than Peers by 2.12
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
16.35
|
-0.39
|
0.48
|
0.39
|
0.93
|
|
Peer Median
|
14.23
|
--
|
--
|
--
|
--
|
Book Value Growth
-54.24
Lower than Peers by 44.11
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
-54.24
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.13
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
--
|
0.02
|
0.02
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
0.01
|
--
|
0.04
|
0.02
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.35
Lower than Peers by 3.46
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
2.35
|
0.84
|
2.97
|
4.37
|
2.53
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
2.35
Lower than Peers by 3.34
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
2.35
|
--
|
--
|
4.37
|
2.53
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
--
|
--
|
--
|
-1,134.96
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
3.72
Lower than Peers by 15.30
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
3.72
|
4.31
|
46.98
|
13.24
|
13.36
|
|
Peer Median
|
19.01
|
--
|
--
|
--
|
--
|
Asset Turnover
0.03
Lower than Peers by 0.03
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
0.03
|
0.04
|
0.03
|
0.01
|
0.01
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
103.52
|
94.59
|
44.22
|
32.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
--
|
0.01
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
13,974.63
|
4,374.74
|
397.01
|
335.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
--
|
-4,280.14
|
-352.79
|
-303.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
-0.73
|
-1.24
|
-0.79
|
-0.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
1.31
Lower than Peers by 4.02
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
1.31
|
29.24
|
1.30
|
0.82
|
0.98
|
|
Peer Median
|
5.33
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.13
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
0.13
|
-0.53
|
-0.06
|
0.18
|
0.33
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
4
Lower than Peers by 138
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
4
|
--
|
--
|
--
|
--
|
|
Peer Median
|
142
|
--
|
--
|
--
|
--
|